Ironwood Pharmaceuticals Raises FY2025 Sales Guidance from $260.000M-$290.000M to $290.000M-$310.000M vs $277.801M Est
Benzinga Newsdesk 11 months ago
NewsGuidance
Ironwood Pharmaceuticals (NASDAQ:IRWD) raises FY2025 sales outlook from $260.000 million-$290.000 million to $290.000 million-$310.000 million vs $277.801 million estimate.
Ironwood Pharmaceuticals (NASDAQ:IRWD) raises FY2025 sales outlook from $260.000 million-$290.000 million to $290.000 million-$310.000 million vs $277.801 million estimate.